Difficulty: Medium
Average Score: 92%
Practice
What are THREE classes of medication used to treat giant coronary artery aneurysms in Kawasaki Disease?
Correct answer
D
Rationale
In the treatment of giant coronary artery aneurysms in Kawasaki Disease, a multi-faceted approach is often required. The correct answer, D) All of the above, encompasses three important classes of medications that play crucial roles in managing this condition.
1. ACE inhibitors (A) are commonly used to reduce the workload on the heart by decreasing blood pressure and limiting the progression of heart failure, which can be beneficial in cases of coronary artery involvement in Kawasaki Disease.
2. Beta blockers (B) help to reduce the heart rate and blood pressure, thereby decreasing the strain on the heart and improving overall cardiac function. They are particularly useful in managing conditions like giant coronary artery aneurysms.
3. Statins (C) are lipid-lowering medications that help to manage cholesterol levels. In the context of Kawasaki Disease, controlling cholesterol levels can be beneficial in reducing the risk of further cardiovascular complications.
Educationally, understanding the rationale behind each class of medication is essential for nursing students specializing in pediatric cardiovascular disorders. By grasping the mechanisms of action and specific indications for ACE inhibitors, beta blockers, and statins, students can provide safe and effective care to pediatric patients with Kawasaki Disease and its associated complications. Additionally, recognizing why the other options are incorrect reinforces critical thinking skills. ACE inhibitors, beta blockers, and statins collectively offer a comprehensive approach to managing giant coronary artery aneurysms in Kawasaki Disease, highlighting the importance of a multidisciplinary treatment strategy in pediatric pharmacology.
1. ACE inhibitors (A) are commonly used to reduce the workload on the heart by decreasing blood pressure and limiting the progression of heart failure, which can be beneficial in cases of coronary artery involvement in Kawasaki Disease.
2. Beta blockers (B) help to reduce the heart rate and blood pressure, thereby decreasing the strain on the heart and improving overall cardiac function. They are particularly useful in managing conditions like giant coronary artery aneurysms.
3. Statins (C) are lipid-lowering medications that help to manage cholesterol levels. In the context of Kawasaki Disease, controlling cholesterol levels can be beneficial in reducing the risk of further cardiovascular complications.
Educationally, understanding the rationale behind each class of medication is essential for nursing students specializing in pediatric cardiovascular disorders. By grasping the mechanisms of action and specific indications for ACE inhibitors, beta blockers, and statins, students can provide safe and effective care to pediatric patients with Kawasaki Disease and its associated complications. Additionally, recognizing why the other options are incorrect reinforces critical thinking skills. ACE inhibitors, beta blockers, and statins collectively offer a comprehensive approach to managing giant coronary artery aneurysms in Kawasaki Disease, highlighting the importance of a multidisciplinary treatment strategy in pediatric pharmacology.